Search

everythinglearnresearchcommunity

for

Search:↓

Pulsed infrared laser can effectively reduce symptoms of pseudofolliculitis barbae.

Methylprednisolone infusions can help some people with severe alopecia regrow hair.

Laser hair removal can cause a severe itchy rash in some allergic individuals, treatable with steroids.

The treatment using phenol and dexamethasone was effective for alopecia areata with no recurrence in 6 months.

The rash worsened due to a fungal infection masked by corticosteroids.

Oral betamethasone mini-pulses effectively treat moderate to severe alopecia areata with manageable side effects.

Congenital alopecia areata may have genetic links and topical corticosteroids are an effective treatment.

Combining pulsed prednisone with tofacitinib can lead to lasting hair regrowth in severe alopecia areata patients.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Neuropsychiatric lupus is a severe form of lupus that needs strong treatment to improve life quality.

Prednisone has risks for lupus patients, isotretinoin is safe for mental health, transplant patients risk skin cancer, and various treatments are effective for specific skin conditions.

The combined therapy significantly increased hair density and was safe for treating hair loss.

Oral mini-pulse methylprednisolone is an effective and safe treatment for alopecia areata.

Dexamethasone mini-pulse therapy is effective for alopecia areata but less effective for those with early onset or hypothyroidism.

Adalimumab helped control a child's severe eye disease when other treatments failed.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Current treatments for alopecia show no significant long-term benefits.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.

The guide explains how to identify and treat children's hair loss, including fungal infections, autoimmune disorders, hairstyle changes, self-correcting conditions, and behavioral therapy for hair-pulling.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.